Literature DB >> 15950571

Absence of seasonal variation in myocardial perfusion, enzymatic infarct size, and mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty.

Giuseppe De Luca1, Harry Suryapranata, Jan Paul Ottervanger, Arnoud W J van 't Hof, Jan C A Hoorntje, A T Marcel Gosselink, Jan-Henk E Dambrink, Menko-Jan de Boer.   

Abstract

The present study investigated any seasonal variation in myocardial perfusion, enzymatic infarct size, and 1-year mortality in 1,548 patients who underwent primary angioplasty for ST-segment elevation myocardial infarction. No seasonal variation was observed in patients' demographic and clinical characteristics. No difference was observed in the prevalence of heart failure at presentation and in myocardial perfusion, enzymatic infarct size, and 1-year mortality.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15950571     DOI： 10.1016/j.amjcard.2005.02.014

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  3 in total

1.  Warm winter is associated with low incidence of ST elevation myocardial infarctions and less frequent acute coronary angiographies in an alpine country.

Authors:  M Wanitschek; H Ulmer; A Süssenbacher; J Dörler; O Pachinger; H F Alber
Journal:  Herz       Date:  2012-06-15       Impact factor: 1.443

2.  Calcineurin and its regulator, RCAN1, confer time-of-day changes in susceptibility of the heart to ischemia/reperfusion.

Authors:  David Rotter; D Bennett Grinsfelder; Valentina Parra; Zully Pedrozo; Sarvjeet Singh; Nita Sachan; Beverly A Rothermel
Journal:  J Mol Cell Cardiol       Date:  2014-05-15       Impact factor: 5.000

3.  Season and myocardial injury in patients with ST-segment elevation myocardial infarction: A cardiac magnetic resonance imaging study.

Authors:  Ik Hyun Park; Woo Jin Jang; Hyun Kyu Cho; Ju Hyeon Oh; Woo Jung Chun; Yong Hwan Park; Mirae Lee; Young Bin Song; Joo-Yong Hahn; Seung-Hyuk Choi; Sang-Chol Lee; Hyeon-Cheol Gwon; Yeon Hyeon Choe
Journal:  PLoS One       Date:  2019-02-08       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.